Abbisko Therapeutics to Present Updated Results from the Phase 2 Study of Irpagratinib in Combination with Atezolizumab for the Treatment of Advanced Hepatocellular Carcinoma at the 2025 ESMO GI Congress SHANGHAI, May 13, 2025 /PRNewswire/ — Abbisko Therapeutics Co., Ltd. (02256.HK) today… CISION PRNewswireMay 13, 2025
Press ReleaseSilver Palace Unveiled: A Detective Adventure ARPG in Victorian Aesthetics The new title features a prosperous metropolis in Victorian aesthetics where players… CISION PRNewswireMay 13, 2025
Press ReleaseTrinasolar Powers Landmark 40 MW Northern Philippine Solar Project by PetroGreen MANILA, Philippines, May 13, 2025 /PRNewswire/ — Trinasolar, a global smart PV and… CISION PRNewswireMay 13, 2025
Press ReleaseTencent Cloud and Vector Group's Offshore Company Launch Japan's First AI Avatar Video Generation Service "AvaMo" Collaboration aims to revolutionize video production of advertisements in Japan TOKYO, May… CISION PRNewswireMay 13, 2025
Press ReleaseDr.AI Empowers Smart Hospitals with Pre-Consults and Real-Time Transcriptions, Winning the COMPUTEX Digital Healthcare Award TAIPEI, May 13, 2025 /PRNewswire/ — Dr.AI (https://www.draiai.com/), an AI medical platform… CISION PRNewswireMay 13, 2025
Press ReleaseNEXCOM Drives Edge AI, Dual 5G, and OT Security Innovation at CommunicAsia 2025 TAIPEI, May 13, 2025 /PRNewswire/ — At CommunicAsia 2025 in Singapore, May… CISION PRNewswireMay 13, 2025
China Liberal Education Holdings Limited Receives Staff Determination Notice from Nasdaq and Plans to Appeal BEIJING, May 13, 2025 /PRNewswire/ — China Liberal Education Holdings Limited ("China… CISION PRNewswireMay 13, 2025
Ascend begins production of high-purity acrylonitrile HOUSTON, May 13, 2025 /PRNewswire/ — Ascend Performance Materials announced today the production… CISION PRNewswireMay 13, 2025
